|
|
|
Insider
Information: |
Aryeh Jason |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
401,047 |
|
Indirect Shares
|
890,847 |
|
|
Direct
Value |
$7,120,240 |
|
|
Indirect Value
|
$5,091,726 |
|
|
Total
Shares |
1,291,894 |
|
|
Total
Value |
$12,211,966 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2016-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
47,287 |
|
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
7,500 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2016-09-16 |
4 |
B |
$5.86 |
$1,732,664 |
I/I |
295,929 |
343,216 |
2.1 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
15,000 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-19 |
4 |
S |
$1.56 |
$79,558 |
I/I |
(51,041) |
337,644 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-22 |
4 |
S |
$1.42 |
$332,365 |
I/I |
(233,468) |
104,176 |
0 |
- |
|
ARLZ |
Aralez Pharmaceuticals In... |
Director |
|
2017-05-23 |
4 |
S |
$1.41 |
$146,878 |
I/I |
(104,176) |
0 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2006-09-27 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
34,150 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2006-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,572,668 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2006-09-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,700 |
|
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2007-05-30 |
4 |
B |
$6.48 |
$21,708 |
I/I |
3,350 |
12,150 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2007-05-30 |
4 |
B |
$6.48 |
$32,400 |
D/D |
5,000 |
29,700 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2007-05-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,000 |
34,700 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2008-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
39,700 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
44,700 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-05-20 |
4 |
B |
$1.48 |
$874 |
D/D |
592 |
45,292 |
2.31 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-05-24 |
4 |
B |
$1.45 |
$4,064 |
D/D |
2,803 |
48,095 |
2.31 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-05-25 |
4 |
B |
$1.43 |
$10,750 |
D/D |
7,500 |
55,595 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,979 |
81,574 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-06-01 |
4 |
B |
$1.48 |
$7,400 |
D/D |
5,000 |
86,574 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-02-23 |
4 |
B |
$9.94 |
$49,700 |
I/I |
5,000 |
267,111 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-10 |
4 |
B |
$10.01 |
$15,125 |
I/I |
1,500 |
3,025 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-11 |
4 |
B |
$9.75 |
$39,355 |
I/I |
4,000 |
3,025 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-14 |
4 |
B |
$9.59 |
$33,900 |
I/I |
3,500 |
271,111 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-15 |
4 |
B |
$9.47 |
$14,235 |
I/I |
1,500 |
272,611 |
2.1 |
- |
|
175 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|